Inhibitory effect of SM-20550, an Na+/H+ exchange inhibitor, on accumulation of leukocytes in ischemia and reperfusion

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 363, Issue 6, 2001, Pages 597-603

  Yamada, Kazuto ^a   Horikawa, Naotsugu ^a   Matsui, Kazuki ^a   Yamamoto, Setsuko ^a   Kawamura, Nobuko ^a   Ohashi, Naohito ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Leukocyte; Myocardial ischemia and reperfusion injury; Na+ H+ exchange

Indexed keywords

MESYLIC ACID DERIVATIVE; N (AMINOIMINOMETHYL) 1,4 DIMETHYL 1H INDOLE 2 CARBOXAMIDE METHANESULFONIC ACID; N AMIDINO 1,4 DIMETHYL 1H INDOLE 2 CARBOXAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; HEART MUSCLE ISCHEMIA; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MALE; NONHUMAN; PROTON SODIUM EXCHANGE; RABBIT; RAT; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY OBSTRUCTION;

AMIDINES; ANIMALS; HEMODYNAMIC PROCESSES; INDOLES; LEUKOCYTES; MALE; MICROCIRCULATION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PHOSPHOPROTEINS; RABBITS; RATS; RATS, WISTAR; SODIUM-HYDROGEN ANTIPORTER;

EID: 0034997501     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000393     Document Type: Article

References (32)

1. Avkiran M (1996) Sodium-hydrogen exchange in myocardial ischemia and reperfusion: a critical determinant of injury? In: Karmazyn M (ed) Myocardial ischemia: mechanism, reperfusion, protection. Birkhäuser, Basel, pp 299-311
2. Campo GM, Squadrito F, Ioculano M, Altavilla D, Zingarelli B, Pollicino AM, Rizzo A, Calapai G, Calandra S, Scuri R, Caputi AP (1994) Protective effects of IRFI-016, a new antioxidant agent, in myocardial damage, following coronary artery occlusion and reperfusion in the rat. Pharmacology 48:157-166
3. Chen LY, Nichols WW, Hendricks JB, Yang BC, Mehta JL (1994) Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog. Cardiovasc Res 28: 1414-1422
4. Chiariello M, Golino P, Cappelli-Bigazzi M, Ambrosio G, Tritto I, Salvatore M (1988) Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion. Am Heart J 115:499-504
5. Chin B, Lip GYH (2000) Cariporide aventis. Curr Opin Invest Drugs 1:340-346
6. Erhardt LRW (1999) GUARD during ischemia against necrosis (GUARDIAN) trial in acute coronary syndromes. Am J Cardiol 83:23G-25G
7. Forman MB, Virmani R, Puett DW (1990) Mechanisms and therapy of myocardial reperfusion injury. Circulation 81 [Suppl IV]:IV69-IV78
8. Frangogiannis NG, Youker KA, Rossen RD, Gwechenberger M, Lindsey MH, Mendoza LH, Michael LH, Ballatyne CM, Smith CW, Entman ML (1998) The microcirculation as a foundation of cardiovascular disease. J Moll Cell Cardiol 30:2567-2576
9. Granger DN, Kubes P (1994) The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55:662-675
10. + exchange inhibition-induced cardioprotection in dogs: effects on neutrophils versus cardiomyocytes. Am J Physiol 279:H1563-H1570
11. + exchange inhibitor SM-20220 attenuates leukocyte adhesion induced by ischemia-reperfusion. J Cardiovasc Pharmacol (in press)
12. + exchange against stunning. J Moll Cell Cardiol 30:509-517
13. 2O2 production. Jpn J Pharmacol [Suppl] 82:53P
14. x. J Cardiovasc Pharmacol Ther 1:49-56
15. Kilgore KS, Park JL, Tanhehco EJ, Booth EA, Marks RM, Lucchesi BR (1998) Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion. J Moll Cell Cardiol 30:75-85
16. Kubes P, Jutila M, Payne D (1995) Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest 95:2510-2519
17. Kurose I, Anderson DC, Miyasaka M, Tamatani T, Paulson JC, Todd RF, Rusche JR, Granger DN (1994) Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res 74:336-343
18. Lefer DJ, Flynn DM, Phillips ML, Ratcliff M, Buda AJ (1994) A novel sialyl Lewis X analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation 90:2390-2401
19. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC (1989) Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia: evidence for neutrophil-mediated reperfusion injury. Circulation 80:1816-1827
20. Lucchesi BR (1990) Modulation of leukocyte-mediated myocardial reperfusion injury. Annu Rev Physiol 52:561-576
21. Mullane KM, Kraemer R, Smith B (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157-167
22. + exchange in ischemia-reperfusion. Basic Res Cardiol 91:191-202
23. + ATPase on cell volume, intercellular pH and migration of human polymorphonuclear leukocytes. Br J Pharmacol 124:627-638
24. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR (1983) Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67: 1016-1023
25. + exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation 101:2902-2908
26. + exchange and its inhibition in cardiac ischemia and reperfusion. Basic Res Cardiol 88:443-455
27. 2+ exchange. Circ Res 65:1045-1056
28. Thiagarajan RR, Winn RK, Harlan JM (1997) The role of leukocyte and endothelial adhesion molecules in ischemia-reperfusion injury. Thromb Haemost 78:310-314
29. Williams FM (1996) Neutrophils and myocardial reperfusion injury. Pharmacol Ther 72:1-12
30. Yamada K, Tojo SJ, Hayashi M, Morooka S (1998) The role of P-selectin, sialyl Lewis X and sulfatide in myocardial ischemia and reperfusion injury. Eur J Pharmacol 346:217-225
31. + exchange inhibitor, in rabbits. Eur J Pharmacol 404:201-202
32. 2+-overload. J Cardiovasc Pharmacol 35:855-862